1. Weekly Pharma Notes: Bristol-Myers Squibb, Johnson & Johnson, Merck And Roche http://y.ahoo.it/OnViRGME by Trefis Team $BMY $JNJ $MRK

  2. Weekly Pharma Notes: Bristol-Myers Squibb, Pfizer, Merck And Roche http://y.ahoo.it/GKX45bDf by Trefis Team $BMY $MRK $PFE

  3. Roche s Sales Inch Up Slowly And Steadily http://y.ahoo.it/JeophcLo by Trefis Team $RHHBY

  4. Roche Earnings Preview: Continued Adoption For Key Cancer Drugs Will Drive Growth ... http://y.ahoo.it/BxoAlyLY by Trefis Team $RHHBY $PFE $MRK

  5. Johnson & Johnson Earnings Preview: Pharma Buisness To Remain Strong http://y.ahoo.it/nXS3jhGm by Trefis Team $JNJ $RHHBY $PFE

  6. Johnson & Johnson s Growth Avenues http://y.ahoo.it/IovlPmMp by Trefis Team $JNJ $PFE $RHHBY

  7. What If Legacy Pharmaceutical & Consumer Business Keeps Falling For Merck? http://y.ahoo.it/RYR72hif by Trefis Team $MRK $BMY $RHHBY

  8. Pfizer s Plan B In Immuno-Oncology: Collaboration With Smaller Companies http://y.ahoo.it/w1qZsoMe by Trefis Team $PFE $MRK $RHHBY

  9. Roche s Purchase Of Genia Is A Long Term Move http://y.ahoo.it/94wnNNgu by Trefis Team $RHHBY $JNJ $ABT

  10. Why Did Merck Pay Such A Huge Premium For Idenix http://y.ahoo.it/9TctWyjJ by Trefis Team $MRK $RHHBY $BMY

  11. What Merck, Bristol-Myers Squibb And Roche Are Doing To Win The Immuno-Oncology Dr... http://y.ahoo.it/TJWLGW6F by Trefis Team $MRK $BMY $RHHBY

  12. Roche Reaffirms Full Year Outlook But Suffers From Currency Movements (publish tod... http://y.ahoo.it/aUTOLE6w by Trefis Team $RHHBY $PFE $MRK

  13. Roche s Competitive Advantage http://y.ahoo.it/XogppqqU by Trefis Team $RHHBY $PFE $MRK

  14. The Breakthrough Biotech That’s Up 500% . . . And Counting http://y.ahoo.it/ZM5G9iMB $INO $PFE $RHHBY

  15. $RHHBY will begin trading ex-dividend on March 6, 2014 and will pay out a dividend of 0.693601 cents for each share - http://y.ahoo.it/4UvdJHoW

  16. Bristol-Myers Squibb Earnings Preview: Immuno-Oncology Drugs In Focus http://y.ahoo.it/Kq6qHjdh by Trefis Team $BMY $MRK $RHHBY

  17. Shopping for Biotech Growth Names: Reni Benjamin http://y.ahoo.it/iNYNGlE7 $BMY $MRK $RHHBY

  18. PSivida: An Extremely Undervalued Ophthalmology Small Cap Investment With Upcoming Catalyst http://y.ahoo.it/CT9ABEXA $PFE $RHHBY $GSK

  19. Roche Strengthening Drug Pipeline As Threat Of Generics Gets Real http://y.ahoo.it/fmEPsvAD by Trefis Team $BMY $MRK $RHHBY

  20. A Compulsion for Brain Science: Zack Lynch http://y.ahoo.it/pIR0EhQW $PFE $RHHBY $MDT

  21. This Biotechnology Platform Could Save Millions of Lives: Patrick Cox http://y.ahoo.it/STvuFvkK $JNJ $PFE $RHHBY

  22. Bristol-Myers Earnings: New Drugs Drive Results, Eliquis Gaining Traction http://y.ahoo.it/XL4S3hEb by Trefis Team $BMY $MRK $RHHBY

  23. Bristol-Myers Earnings Preview: New Drugs To Maintain Growth http://y.ahoo.it/VBl6l7ME by Trefis Team $BMY $MRK $RHHBY

  24. Oncology Drugs Drive Roche s Revenue, Full Year Outlook Confirmed by Trefis Team $BMY $MRK $RHHBY

  25. Roche Earnings Preview: Oncology Drugs In Focus http://y.ahoo.it/tX4bPUy6 by Trefis Team $RHHBY